This medical solution company with the use of plasma established in a KAIST lab in 2015 was selected as Soon-to-be Unicorn, one of the 100 Materials · Parts · Equipment Startups, and innovative medical device company, etc. based on its outstanding technical skills in plasma.
It has been recognized for its technology as filing about 187 patents so far, being awarded in Korea.
Technology Awards, and exporting its technologies reliable in the prevention · rehabilitation medical industry to around 50 countries.
Based on smart corporate culture and innovative thinking, it continues to develop mutual-respect culture with all the employees’ open-minded thinking and values.
Founded at KAIST Lab in 2015, Korean Government selected as a “Soon-to-be Unicorn”
Founded at KAIST Lab in 2015, Korean Government selected as a “Soon-to-be Unicorn”
Founded at KAIST Lab in 2015, Korean Government selected as a “Soon-to-be Unicorn”
Founded at KAIST Lab in 2015, Korean Government selected as a “Soon-to-be Unicorn”
The biological inactivation of Plasmapp is the world’s fastest low-temperature sterilization solution using sterilant direct injection technology with an impermeable sterile package to maximize sterilant efficiency. This solution prevents thermal damage to delicate medical devices and secures user safety in the sterilization process using differentiated plasma technology of Plasmapp.
The regenerative activation of Plasmapp is the world’s best surface treatment solution using vacuum plasma technology to remove impurities from the surface of implantable devices including medical implant and increase surface energy. The activated surface improves biocompatibility and shortens the surgery healing time with increasing its success rate.
The stimulative therapy of Plasmapp is the world’s best low-temperature therapy solution using vacuum plasma sterilization and stimulative activation technology to maximize treatment efficiency for the biological tissues. In skin treatment, vacuum plasma technology enables stable and effective treatment without thermal damage on skin tissues.
Plasmapp Co., Ltd.
Sales & Marketing | 59, Seocho-daero 77-gil, Seocho-gu, Seoul, Republic of Korea [06611]
R&D 1 | 9, Giheungdanji-ro 24beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, Republic of Korea [17086]
R&D 2 | 372, Dongbu-daero, Osan-si, Gyeonggi-do, Republic of Korea [18151]
Factory | 102, Cheombok-ro, Dong-gu, Daegu, Republic of Korea [41061]
HQ | 125, Gwahak-ro, Yuseong-gu, Daejeon, Republic of Korea [34141]